Sign In
Buy ABMD
$381.02
+0 (+0%)
At Close: Mar 20, 2023
Getinge's subsidiary Maquet Cardiovascular receives adverse jury trial verdict in patent infringement dispute with Abiomed in the U.S.
01:26pm, Thursday, 28'th May 2026
GOTHENBURG, Sweden, May 28, 2026 /PRNewswire/ -- Getinge today announces that a jury in the United States District Court for the District of Massachusetts has delivered a verdict in favor of Abiomed
Dublin, March 04, 2025 (GLOBE NEWSWIRE) -- The "IoMT Wearable Devices Patent Landscape Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering. The IoMT wearable devi
US FDA classifies recall of Abiomed's blood pumps as most serious
11:10am, Thursday, 21'st Mar 2024
The U.S. health regulator on Thursday classified the recall of blood pumps by Abiomed, a Johnson & Johnson company, as the most serious and said their use could cause serious injuries or death.
3 Reasons to Retain Abiomed (ABMD) Stock in Your Portfolio
09:02am, Thursday, 22'nd Dec 2022
Investors remain optimistic about Abiomed (ABMD) due to strength in its Impella product line.
FDA Approves Impella ECP Pivotal Heart Pump and First Patients Enrolled in Pivotal Clinical Trial
09:00am, Wednesday, 21'st Dec 2022
DANVERS, Mass.--( BUSINESS WIRE )--Abiomed (Nasdaq: ABMD) announces the United States Food and Drug Administration (FDA) has approved the version of Impella ECP that will be used in the Impella ECP Pi
Warren Buffett Loves These Stocks. Should You Buy Them Before 2023?
05:30am, Friday, 16'th Dec 2022
There's a lot more ahead for these market giants.
Johnson & Johnson Announces Extension of Abiomed Tender Offer to December 21, 2022
07:15am, Wednesday, 14'th Dec 2022
NEW BRUNSWICK, N.J.--( BUSINESS WIRE )--Johnson & Johnson (NYSE: JNJ), the world's largest, most diversified healthcare products company, today announced that Athos Merger Sub, Inc. (“Offeror”), a
This Monster Dividend Stock Isn't Done Growing
02:00pm, Thursday, 08'th Dec 2022 The Motley Fool
Is another deal on the way for Johnson & Johnson?
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ELVT, OPNT, BNFT, ABMD
12:07pm, Tuesday, 06'th Dec 2022
NEW YORK , Dec. 6, 2022 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches
First Patients in the World Treated with Impella RP Flex with SmartAssist
08:03am, Monday, 05'th Dec 2022
DANVERS, Mass.--( BUSINESS WIRE )--Abiomed (Nasdaq: ABMD) announces the first three patients in the world have been treated with Impella RP Flex with SmartAssist, Abiomed's newest heart pump for patie
Tracking Al Gore's Generation Investment Management Portfolio - Q3 2022 Update
05:23am, Monday, 05'th Dec 2022 Seeking Alpha
Al Gore's 13F portfolio value decreased from $18.35B to $16.86B this quarter. Find out Generation Investment Management's holdings and trades for Q2 2022.
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
10:15am, Friday, 02'nd Dec 2022 The Motley Fool
This space is ripe with opportunities for investors.
Why Is Abiomed (ABMD) Up 1.2% Since Last Earnings Report?
04:31pm, Thursday, 01'st Dec 2022 Zacks Investment Research
Abiomed (ABMD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
These 20 stocks soared in November with gains of 22% or more after Powell ignites rally
11:41am, Thursday, 01'st Dec 2022 MarketWatch
Chip makers including AMD and Nvidia rebound on expectations interest rates will rise more slowly.
Analyst Forecasts $101-117/Share Offer Price For Horizon Therapeutics' Buyout
06:52pm, Wednesday, 30'th Nov 2022 Benzinga
Horizon Therapeutics Plc (NASDAQ: HZNP) confirmed it's engaged in preliminary talks with Amgen Inc (NASDAQ: AMGN), Janssen Global Service, and Sanofi SA SNY on potential takeover offers for th
